02Jun/13

Lou Reed Speaks on Liver Transplant Surgery, Plans on Returning to the Stage – 411mania.com


TopNews United States

Lou Reed Speaks on Liver Transplant Surgery, Plans on Returning to the Stage
411mania.com
Lou Reed posted a message on his Facebook talked about his recent life-saving liver transplant surgery and said he is “feeling better and stronger than ever.” Reed underwent the operation last month. He’s now posted a new message to fans on Facebook,
Liver Transplant Surgery Recovery Continues for Lou ReedTopNews United States
Lou Reed saved by liver transplant after years of drugs and alcohol take their Telegraph.co.uk
Lou Reed’s Liver Transplant Successful; Was Dying after a Life that Celebrated KpopStarz
Hollywood Reporter
all 101 news articles »
02Jun/13

Kuznetsova through to quarters in vintage style – Reuters India


Indian Express

Kuznetsova through to quarters in vintage style
Reuters India
The world number 39, Kuznetsova prevailed after two hours 21 minutes of tennis featuring slides, drop shots and lung-burning rallies, far from the usual baseline-biffing contests in force in women’s tennis. After being broken, Kuznetsova won three
Azarenka revels on shifting sands in ParisTimes of India

all 297 news articles »

02Jun/13

Highlights from ASCO: Bayer's Nexavar; Novartis' Afinitor; and Amgen's … – The Pharma Letter

Highlights from ASCO: Bayer’s Nexavar; Novartis’ Afinitor; and Amgen’s
The Pharma Letter
Also at ASCO yesterday, Swiss drug major Novartis (NOVN: VX) presented results from a pivotal Phase III trial of a treatment regimen including Afinitor (everolimus) tablets in women with human epidermal growth factor receptor-2 positive (HER2 positive)

and more »

02Jun/13

Novartis pivotal Phase III trial shows Afinitor significantly delays tumor … – MarketWatch (press release)

Novartis pivotal Phase III trial shows Afinitor significantly delays tumor
MarketWatch (press release)
EAST HANOVER, N.J., June 2, 2013 /PRNewswire via COMTEX/ — Novartis today presented results from a pivotal Phase III trial of a treatment regimen including Afinitor� (everolimus) tablets in women with human epidermal growth factor receptor-2 positive

and more »